Terms: = Kidney tumors AND MLLT1, ENL, 4298, ENSG00000130382, Q03111, YEATS1, LTG19
7 results:
1. Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study.
Gadd S; Huff V; Skol AD; Renfro LA; Fernandez CV; Mullen EA; Jones CD; Hoadley KA; Yap KL; Ramirez NC; Aris S; Phung QH; Perlman EJ
Cell Rep Med; 2022 Jun; 3(6):100644. PubMed ID: 35617957
[TBL] [Abstract] [Full Text] [Related]
2. A proteolysis-targeting chimera molecule selectively degrades enl and inhibits malignant gene expression and tumor growth.
Li X; Yao Y; Wu F; Song Y
J Hematol Oncol; 2022 Apr; 15(1):41. PubMed ID: 35395864
[TBL] [Abstract] [Full Text] [Related]
3. The Intrinsically Disordered Proteins MLLT3 (AF9) and mllt1 (enl) - Multimodal Transcriptional Switches With Roles in Normal Hematopoiesis, MLL Fusion Leukemia, and kidney Cancer.
Kabra A; Bushweller J
J Mol Biol; 2022 Jan; 434(1):167117. PubMed ID: 34174329
[TBL] [Abstract] [Full Text] [Related]
4. A Children's Oncology Group and TARGET initiative exploring the genetic landscape of Wilms tumor.
Gadd S; Huff V; Walz AL; Ooms AHAG; Armstrong AE; Gerhard DS; Smith MA; Auvil JMG; Meerzaman D; Chen QR; Hsu CH; Yan C; Nguyen C; Hu Y; Hermida LC; Davidsen T; Gesuwan P; Ma Y; Zong Z; Mungall AJ; Moore RA; Marra MA; Dome JS; Mullighan CG; Ma J; Wheeler DA; Hampton OA; Ross N; Gastier-Foster JM; Arold ST; Perlman EJ
Nat Genet; 2017 Oct; 49(10):1487-1494. PubMed ID: 28825729
[TBL] [Abstract] [Full Text] [Related]
5. mllt1 YEATS domain mutations in clinically distinctive Favourable Histology Wilms tumours.
Perlman EJ; Gadd S; Arold ST; Radhakrishnan A; Gerhard DS; Jennings L; Huff V; Guidry Auvil JM; Davidsen TM; Dome JS; Meerzaman D; Hsu CH; Nguyen C; Anderson J; Ma Y; Mungall AJ; Moore RA; Marra MA; Mullighan CG; Ma J; Wheeler DA; Hampton OA; Gastier-Foster JM; Ross N; Smith MA
Nat Commun; 2015 Dec; 6():10013. PubMed ID: 26635203
[TBL] [Abstract] [Full Text] [Related]
6. Occupational risk factors for renal cell carcinoma: agent-specific results from a case-control study in Germany. MURC Study Group. Multicenter urothelial and renal cancer study.
Pesch B; Haerting J; Ranft U; Klimpel A; Oelschlägel B; Schill W
Int J Epidemiol; 2000 Dec; 29(6):1014-24. PubMed ID: 11101542
[TBL] [Abstract] [Full Text] [Related]
7. The HRX proto-oncogene product is widely expressed in human tissues and localizes to nuclear structures.
Butler LH; Slany R; Cui X; Cleary ML; Mason DY
Blood; 1997 May; 89(9):3361-70. PubMed ID: 9129043
[TBL] [Abstract] [Full Text] [Related]
